Variant report
Variant | esv3468608 |
---|---|
Chromosome Location | chr5:178110146-178115244 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185687817 | chr5:178110152-178110153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs377655403 | chr5:178110167-178110168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs75531276 | chr5:178110170-178110171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs569273625 | chr5:178110173-178110174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs375127690 | chr5:178110207-178110208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs368046926 | chr5:178110208-178110209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs371904488 | chr5:178110214-178110215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs534524234 | chr5:178110218-178110219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs147120885 | chr5:178110229-178110230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs577577409 | chr5:178110259-178110260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs189877370 | chr5:178110290-178110291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs138473306 | chr5:178110307-178110308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs574459748 | chr5:178110308-178110309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs541902556 | chr5:178110311-178110312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs534368501 | chr5:178110312-178110313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs548054519 | chr5:178110318-178110319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559766000 | chr5:178110406-178110407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs527273361 | chr5:178110451-178110452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs545727575 | chr5:178110487-178110488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs77856350 | chr5:178110497-178110498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs531623082 | chr5:178110505-178110506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs182040147 | chr5:178110519-178110520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs73334807 | chr5:178110543-178110544 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs141967123 | chr5:178110626-178110627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs76481071 | chr5:178110628-178110629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs386695484 | chr5:178110634-178110635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs566905657 | chr5:178110648-178110649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs57538069 | chr5:178110649-178110650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73334810 | chr5:178110679-178110680 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs202190693 | chr5:178110705-178110706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs538494199 | chr5:178110888-178110889 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs184682456 | chr5:178110913-178110914 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs375534914 | chr5:178110970-178110971 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs76617910 | chr5:178110993-178110994 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs541591247 | chr5:178111006-178111007 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs150669344 | chr5:178111008-178111009 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188781475 | chr5:178111012-178111013 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs139067441 | chr5:178111027-178111028 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs536714025 | chr5:178111029-178111030 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs563691455 | chr5:178111077-178111078 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs74485165 | chr5:178111163-178111164 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs7732325 | chr5:178111284-178111285 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs180873606 | chr5:178111318-178111319 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs78794063 | chr5:178111320-178111321 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs547579187 | chr5:178111333-178111334 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs149489803 | chr5:178111354-178111355 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs17081596 | chr5:178111441-178111442 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs55761260 | chr5:178111475-178111476 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs145929757 | chr5:178111480-178111481 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs139831677 | chr5:178111542-178111543 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Prostate cancer | 18632612 | CNVD |
epilepsy | 18472482 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Sotos syndrome | 21572526 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Sotos syndrome | 17561922 | CNVD |
Sotos syndrome | 16773131 | CNVD |
Mental retardation | 16773131 | CNVD |
Sotos syndrome | 22470819 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Lung cancer | 17297452 | CNVD |
Cancer | 20164920 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Sotos syndrome | 22283845 | CNVD |
Breast cancer | 16272173 | CNVD |
Sotos syndrome | 20503325 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Congenital Hypertrichosis Syndrome | 21636067 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 19181860 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ehlers-danlos syndrome | 17576883 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 19246517 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Breast cancer | 21990379 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:178109400-178110800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
2 | chr5:178109800-178110800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
3 | chr5:178110200-178113200 | Enhancers | Primary monocytes fromperipheralblood | blood |
4 | chr5:178110400-178111800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
5 | chr5:178110800-178111200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr5:178110800-178111600 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
7 | chr5:178110800-178111800 | Enhancers | K562 | blood |
8 | chr5:178110800-178112000 | Flanking Active TSS | Primary neutrophils fromperipheralblood | blood |
9 | chr5:178111600-178113400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
10 | chr5:178112000-178115400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
11 | chr5:178112200-178112800 | Enhancers | Placenta | Placenta |
12 | chr5:178112800-178113400 | Flanking Active TSS | Placenta | Placenta |
13 | chr5:178113200-178115200 | Weak transcription | Primary monocytes fromperipheralblood | blood |
14 | chr5:178113400-178113800 | Enhancers | Placenta | Placenta |
15 | chr5:178113400-178115000 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
16 | chr5:178115000-178115400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
17 | chr5:178115200-178116400 | Enhancers | Primary monocytes fromperipheralblood | blood |